{"text": "our results suggest that the combination of low dose cisplatin and scriptaid is cytotoxic to NSCLC lines, can overcome hypoxia induced resistance and mutant p53- induced instability often associated with this cancer, and has the potential to be an effective therapeutic modality.", "denotations": [{"id": "T1", "obj": "gene", "span": {"begin": 157, "end": 161}}, {"id": "T2", "obj": "disease", "span": {"begin": 209, "end": 215}}]}
